Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp (ADPT), sold 52,046 shares at $6.98 ($363K) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Open-market sale of $363k ADPT by Chief Commercial Officer, MRD. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.98 | 26,023 | $182K | 50.0% |
| 2 | $6.98 | 26,023 | $182K | 50.0% |
| Total | $6.98 avg | 52,046 | $363K | 100% |
| Filing → |
| ADPT | SELL | 2026-08-12 | $75K | — | Filing → |
| ADPT | SELL | 2026-08-03 | $31K | — | Filing → |
| ADPT | SELL | 2026-07-20 | $115K | — | Filing → |